Purpose: We evaluate the outcome, clarify the patterns of failure and sugge
st treatment strategies for sarcoma in the spermatic cord.
Materials and Methods: Between 1956 and 1998, 32 patients with spermatic co
rd sarcoma were treated at M. D. Anderson Cancer Center. A retrospective re
view of disease outcome, patterns of relapse and patient survival was perfo
rmed.
Results: Histological subtypes of sarcoma were malignant fibrous histiocyto
ma in 12 patients, leiomyosarcoma in 6, liposarcoma in 8 and other subtypes
in 6. All except 2 patients underwent radical orchiectomy with or without
additional resection to achieve negative margins. Margins were microscopica
lly negative in 29 cases and positive in 3. There were 3 patients who recei
ved adjuvant radiation to the surgical site. With a median followup of 9 ye
ars the 10 and 15-year actuarial local control, distant metastasis-free and
overall survival rates were 72% and 61%, 85% and 85%, and 63% and 52%, res
pectively. The major pattern of failure was local recurrence that occurred
in 8 of the 12 patients in whom disease relapsed and was the sole site of r
elapse in 7. Pelvic nodes had relapsed in 2 patients and para-aortic nodes
in 1. Hematogenous metastases had developed in 4 patients. Of the 7 cases o
f disease that recurred locally only 3 were salvaged. No relapse occurred i
n the 3 patients treated with combined surgery and radiation.
Conclusions: Spermatic cord sarcoma has a high propensity for local recurre
nce after surgery. Nodal relapse is less frequent than commonly believed. B
ecause of the relatively high local failure rate seen in surgery alone and
durable local control noted in 3 patients treated with surgery plus radioth
erapy, combined modality treatment should be considered in those with sperm
atic cord sarcoma who are believed to be at high risk for local failure.